Traditional neuroimaging studies in depression have predominantly focused on localized activity anomalies, measuring how specific brain regions become hypoactive or hyperactive. The Mount Sinai team, however, reframed depression within the theoretical framework of dynamical systems theory. This perspective considers the brain as a complex system constantly shifting between multiple large-scale functional states rather than as a static assembly of independently functioning areas. The brain’s movement among these states, and the energetic “ease” or difficulty with which transitions occur, is central to comprehending the pathology and persistence of depressive symptoms.

To probe these dynamics, the researchers utilized resting-state functional Magnetic Resonance Imaging (fMRI), capturing the brain’s functional connectivity patterns when participants were awake but not engaged in any specific task. Complementing this, diffusion tractography mapped the structural white-matter pathways—essentially the brain’s wiring—that constrain functional interactions. Integrating these data sets allowed the team to construct an energy landscape model, providing a mathematical representation of the energetic barriers and wells that govern transitions between brain states.

Their analyses revealed that in people with depression, certain brain states—characterized by distinct connectivity patterns—were encountered more frequently yet exhibited much shorter dwell times before switching. This counterintuitive combination suggests that rather than simply experiencing heightened or diminished activity, depressive brains manifest instability in the temporal architecture of their functional states. Such instability challenges the longstanding notion that depression corresponds to static hyperactive or hypoactive network configurations.

More intriguingly, the transitions between these brain states exhibited marked asymmetries in their energetics. Certain trajectories into depressive brain states were more energetically favored and easier for the brain to enter than to exit. Individuals with depression tended to traverse energetically costly pathways even when less demanding alternative routes were available, creating a neurodynamic “trap” that reinforces maladaptive patterns over time. This pattern of dynamic entrapment aligns with clinical descriptions from patients who often report feeling stuck in cycles of negative thoughts and emotions.

Specifically, the brain’s energy landscape in depression resembles a rugged terrain marked by deep valleys representing maladaptive states and high ridges posing substantial energetic barriers. The difficulty to escape these valleys elucidates why depressive symptoms can persist despite attempts at cognitive or pharmacological interventions. This novel insight challenges standard treatment paradigms, which have typically targeted altering activity levels rather than modifying intrinsic brain dynamics.

Senior author Dr. Yael Jacob highlighted the clinical implications of these findings, stating that understanding depression as a disorder of dynamic state transitions opens new avenues for precision medicine. By quantifying how readily the brain can shift out of maladaptive states, clinicians may better tailor interventions both in timing and targeting. For instance, neuromodulatory techniques such as transcranial magnetic stimulation (TMS) or deep brain stimulation (DBS) could be optimized to apply stimuli precisely when the brain is most amenable to transition, thereby improving efficacy.

This framework also provides a compelling explanation for the heterogeneous response to antidepressant treatments observed across individuals. By modeling the brain’s energy landscape pre- and post-treatment, it may become possible to predict which therapies are more likely to remodel the brain’s dynamic architecture successfully. Moreover, this approach holds promise for evaluating emerging pharmacotherapies like ketamine and psychedelics, which are believed to induce rapid shifts in brain network connectivity.

Postdoctoral fellow Ülgen Kilic, the study’s first author, emphasized that their results move beyond simplistic biomarkers and pave the way toward a mechanistic understanding of depression grounded in physics and mathematics. This interdisciplinary integration of neuroimaging and dynamical systems could redefine psychiatric diagnostics and catalyze novel therapeutic strategies designed to “reshape” brain dynamics rather than merely suppress symptoms.

Beyond depression, Mount Sinai’s team plans to investigate whether similar brain-state dynamic signatures are present in other psychiatric conditions such as anxiety, bipolar disorder, and schizophrenia. Understanding these overarching principles of brain activity transitions could illuminate common neural mechanisms underpinning diverse mental illnesses and hence foster more unified treatment approaches.

Furthermore, longitudinal studies are underway to assess how these spatiotemporal brain-state dynamics evolve over the course of treatment and whether specific changes correlate with clinical improvement. Such work could ultimately lead to objective, brain-based metrics of treatment response, enabling clinicians to monitor and adjust interventions with unprecedented precision.

Dr. James Murrough, director of the Depression and Anxiety Discovery Center and co-author of the paper, remarked that this study represents a critical leap forward in psychiatric neuroscience. By conceptualizing depression as an emergent property of altered brain system dynamics, researchers are now better equipped to decode the complexity of mental illness in a way that traditional region-centric models have failed to achieve.

The findings reported by the Icahn School of Medicine at Mount Sinai exemplify the increasing power of interdisciplinary neuroscience, merging neuroimaging, computational modeling, and clinical research. Such work not only deepens our fundamental understanding of depression but also holds transformative potential for developing targeted, biologically informed interventions that can improve the lives of millions suffering worldwide.

As the field moves forward, the integration of dynamical systems theory with neurobiological data heralds a paradigm shift, emphasizing the brain’s fluid functional architecture over static snapshots. This dynamic viewpoint acknowledges the temporal ebb and flow governing mood, cognition, and behavior, unlocking novel pathways toward diagnosing, monitoring, and treating complex psychiatric disorders like depression with far greater accuracy and effectiveness than ever before.

Subject of Research: People

Article Title: Spatiotemporal asymmetries on brain energy landscape uncover system entrapment related to depression severity

News Publication Date: 23-Apr-2026

Web References: https://doi.org/10.1038/s41467-026-71961-4

References: Nature Communications, DOI: 10.1038/s41467-026-71961-4

Keywords: Depression, Neuroimaging, Functional magnetic resonance imaging, Dynamical systems

The subcallosal cingulate cortex (SCC), nestled deep within the medial prefrontal cortex, plays a central role in emotional processing, making it a prime target for intervention in major depressive disorder (MDD). Traditional treatments have often left clinicians grappling with inconsistent patient responses, highlighting the necessity to dive deeper into neural circuitry to understand why some individuals respond favorably while others do not. The review comprehensively analyzes brain stimulation-induced changes in SCC connectivity, offering profound insights into the dynamic shifts within the depressive brain’s functional architecture.

Advances in neuroimaging techniques, particularly resting-state functional magnetic resonance imaging (rs-fMRI), have opened a window into the brain’s functional connectome—mapping how distinct regions communicate at rest. The studies compiled reveal a distinct pattern: aberrant hyperconnectivity between the SCC and limbic structures often correlates with depressive symptomatology. Intriguingly, brain stimulation modalities such as deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS) appear to remodel these aberrant networks, often normalizing connectivity patterns and coinciding with clinical improvement.

Key to the review’s significance is its focus on the predictive value of pretreatment SCC connectivity profiles. By leveraging sophisticated analytic models, the authors highlight that specific baseline connectivity metrics may forecast patient responsiveness to brain stimulation therapies. This suggests a potential paradigm shift towards biomarker-driven personalized treatment, enabling clinicians to tailor interventions based on individual neural signatures rather than a one-size-fits-all approach that has long dominated psychiatric practice.

Deep brain stimulation targeting the SCC, first popularized for its efficacy in treatment-resistant depression, operates by delivering precise electrical impulses to modulate pathological neural activity. The review collates data demonstrating that effective DBS reconfigures functional coupling not only locally within the SCC but also downstream in connected networks encompassing the prefrontal cortex and subcortical limbic regions. These network-level modulations appear essential for mood stabilization, underscoring the SCC’s role as a hub in the neurocircuitry of depression.

Similarly, noninvasive brain stimulation approaches such as repetitive TMS have shown promise in altering cortical excitability with downstream impacts on subcortical structures like the SCC. The review underscores nuanced differences in the connectivity changes induced by invasive versus noninvasive techniques, reflecting the complexity of neurophysiological responses and the necessity for refined targeting protocols to maximize therapeutic benefits while minimizing side effects.

A remarkable finding emerging from the synthesis is the consistent association between decreased SCC hyperconnectivity post-stimulation and symptom remission. This reinforces the notion that maladaptive hyperconnectivity within mood-regulating circuits is a neural hallmark of depression, a reversible state rather than a fixed structural anomaly. The plasticity unveiled offers hope that depression’s grip on brain networks can be loosened through appropriately timed and calibrated neuromodulatory interventions.

The mechanistic pathways underpinning these connectivity changes are multifaceted. Brain stimulation likely affects synaptic efficacy, neurotransmitter release, and neuroinflammation dynamics within these networks. The review advocates for future mechanistic studies combining multimodal imaging, electrophysiology, and molecular techniques to decode these processes further. Understanding these mechanisms would catalyze the development of next-generation brain stimulation protocols with enhanced precision and durability.

Moreover, the systemic review touches on the temporal dynamics of connectivity changes relative to clinical timelines. Some connectivity alterations manifest rapidly post-stimulation, while others consolidate gradually with sustained treatment, reflecting complex neuroadaptive processes that may underlie sustained remission versus relapse. Tracking these trajectories could enrich clinical monitoring and optimize treatment schedules.

The authors also emphasize the heterogeneity of depression as a disorder, where distinct connectivity signatures may delineate subtypes with differential treatment sensitivities. Such stratification could transform clinical trials by enabling cohort enrichment and improving signal detection, thereby accelerating therapeutic innovation and regulatory approval pathways.

While the focus on SCC connectivity offers compelling insights, the review also situates this within a broader neurocircuitry framework involving interconnected networks such as the default mode network, salience network, and fronto-limbic circuits. This integrative perspective acknowledges depression as a disorder of distributed neural systems rather than isolated regions, advocating for comprehensive network-level assessments in future research.

Technological advancements such as closed-loop DBS systems that adjust stimulation parameters in real-time based on neural feedback hold promise in augmenting treatment efficacy. The review hints at these frontiers, suggesting that integrating connectivity biomarkers with adaptive stimulation could herald a new era in precision psychiatry.

In sum, this systematic review delivers an exceptional synthesis of current literature on the subcallosal cingulate cortex’s functional connectivity in depression, emphasizing brain stimulation-induced changes and the prognostic value of pretreatment connectivity. It elevates the scientific discourse beyond phenomenology into mechanistic understanding, heralding a future where brain network-informed interventions offer hope for millions grappling with treatment-resistant depression.

Through elucidating the neurofunctional correlates of antidepressant response and resistance, the work of Henensal and colleagues paves the way toward transformative, biomarker-guided clinical pathways. As brain stimulation technologies continue to evolve and integrate with neuroimaging biomarkers, the vision of precision neuromodulation in psychiatry inches ever closer to reality. This review stands as a definitive reference point for clinicians and neuroscientists seeking to decode the brain’s complex mood-regulatory networks and tailor treatments with unparalleled precision.

Subject of Research:
Subcallosal cingulate functional connectivity and its role in depression treatment response to brain stimulation therapies.

Article Title:
Subcallosal cingulate functional connectivity in depression: a systematic review of brain stimulation–induced changes and pretreatment connectivity predictors.

Article References:
Henensal, A., Attali, D., Aubry, JF. et al. Subcallosal cingulate functional connectivity in depression: a systematic review of brain stimulation–induced changes and pretreatment connectivity predictors. Transl Psychiatry (2026). https://doi.org/10.1038/s41398-026-03999-3

Image Credits: AI Generated

DOI:
https://doi.org/10.1038/s41398-026-03999-3

The hippocampus, a complex brain structure critical for memory and emotional processing, comprises several subfields with specialized functions. Despite its known involvement in depressive disorders, previous investigations largely treated it as a homogeneous entity. This new study challenges that approach by dissecting the hippocampus into its constituent subregions to map disruptions specific to somatic depression.

A cohort of 261 individuals participated in this investigation, including 190 patients diagnosed with major depressive disorder and 71 healthy controls. Using advanced 3.0 Tesla resting-state magnetic resonance imaging (MRI), the team meticulously measured both grey matter volume (GMV) and functional connectivity (FC) within hippocampal subregions. These neuroimaging metrics served as indicators of structural integrity and functional communication between brain regions respectively.

Remarkably, the study identified significant reductions in grey matter volume localized in the left and right hippocampus amygdala transition area (HATA) among patients suffering from somatic depression compared to their non-somatic counterparts. The amygdala transition area, an anatomically intricate nexus linking hippocampus and amygdala, is crucial for integrating emotional and sensory information, which may underpin somatic symptomatology.

Beyond structural alterations, functional connectivity analyses revealed diminished communication between the left HATA and the left superior occipital gyrus as well as between the right HATA and the left middle temporal gyrus in somatic depression patients. These disrupted networks suggest impaired integration of sensory and cognitive processing pathways, potentially explaining the somatization phenomena observed clinically.

Of particular significance, the strength of connectivity between the left HATA and left superior occipital gyrus correlated positively with clinical measures of depression severity, including scores from the Hamilton Depression Rating Scale (HAMD-17) and assessments of cognitive disturbance. This finding not only substantiates a link between hippocampal network dysfunction and depressive symptomatology but also offers a promising biomarker for disease severity.

The implications of these findings are multifaceted. They underscore the importance of viewing the hippocampus as a heterogeneous structure where specific subregions contribute differentially to psychopathology. Identifying the HATA as a locus of disruption enhances the precision of neurobiological models of somatic depression and opens avenues for targeted neuromodulatory treatments.

Moreover, the involvement of sensory processing areas like the superior occipital gyrus emphasizes the cross-talk between limbic structures and cortical sensory regions, possibly elucidating mechanisms by which emotional disturbances manifest somatically. This cross-modal interaction highlights a neural pathway that could be manipulated therapeutically to alleviate somatic symptoms.

The study’s methodology, combining high-resolution imaging with rigorous clinical phenotyping, represents a methodological advance in psychiatric neuroimaging. It sets the stage for further work aimed at unraveling complex brain-behavior relationships in depressive subtypes, with potential to tailor interventions based upon distinct neurobiological signatures.

Future research may expand this approach to other subfields within the hippocampus and examine longitudinal changes in GMV and FC as these relate to treatment response. Additionally, exploring how these hippocampal abnormalities interact with other key brain circuits implicated in mood regulation will deepen our understanding of depression’s heterogeneity.

By pinpointing neurobiological markers specific to somatic depression, this study paves the way not only for refined diagnostic criteria but also for personalized therapeutic strategies. As precision psychiatry gains momentum, such targeted insights into brain network dysfunction hold promise for mitigating the substantial burden of depressive disorders worldwide.

In conclusion, the structural and functional aberrations of the hippocampus, particularly within the amygdala transition area, represent a neurobiological hallmark of somatic depression. The connectivity disruptions involving sensory cortical regions may serve as a novel target for neuroregulation, offering hope for innovative treatment modalities tailored to this debilitating subtype of depression.

Subject of Research: Neurobiological distinctions of somatic depression focusing on hippocampal subregions.

Article Title: Brain structural and functional aberrant of hippocampal subregions was associated with somatic depression.

Article References:
Juan, Q., Liuyi, Z., Yuxuan, H. et al. Brain structural and functional aberrant of hippocampal subregions was associated with somatic depression. BMC Psychiatry 25, 978 (2025). https://doi.org/10.1186/s12888-025-07386-y

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12888-025-07386-y

Major depressive disorder remains one of the most complex and pervasive mental health challenges worldwide. Traditional treatment modalities, including pharmacotherapy and psychotherapy, often fall short, compelling scientists to explore neuromodulation techniques such as noninvasive brain stimulation (NIBS). While NIBS presents a promising alternative, its clinical efficacy has been limited by the absence of individualized targeting approaches that account for the vast functional and topological diversity of brain networks implicated in depression.

Central to this study is the utilization of electroencephalography (EEG) to capture the dynamic patterns of electrical activity across brain networks in both healthy individuals and those diagnosed with MDD. Analyzing resting-state EEG from 30 healthy controls and 34 patients, the researchers examined functional connectivity across five frequency bands by applying sophisticated measures such as phase locking value (PLV), amplitude envelope correlation (AEC), and weighted phase lag index (wPLI). These complementary metrics provide a nuanced depiction of interaction styles within the brain, encompassing both linear and nonlinear coupling properties.

The researchers integrated spectral graph embedding techniques with structural controllability theory to reveal key nodes within the brain’s network architecture that are pivotal for exerting influence over neural dynamics. This approach allowed them to map the brain’s control points particularly relevant to the aberrant network configurations observed in MDD. Spectral graph embedding distills complex connectivity matrices into interpretable low-dimensional representations, facilitating the identification of candidate stimulation sites based on their potential for modulating network behavior.

To optimize stimulation parameters, including site selection, frequency band, and stimulation amplitude, a cutting-edge multi-objective evolutionary algorithm known as NSGA-II was employed. This algorithm balances competing objectives such as minimizing the energy required to control targeted brain states, maximizing improvements in global network efficiency, and achieving structural restoration aligned with healthy controls. By formalizing these objectives, the study delivers tailored stimulation protocols that attempt to rectify the underlying network dysfunction characteristic of depression.

The validation of these targeted interventions was conducted through Kuramoto-based neural simulations that model the synchronization dynamics among coupled neuronal oscillators. Such simulations enable in-silico experimentation of stimulation effects, measuring critical network properties like global synchrony, modularity, and local efficiency. The results underscored that simulated stimulation enhanced overall network synchrony in MDD subjects, reduced segregated community structures, and bolstered local processing efficiency, supporting the theoretical potential of these personalized strategies.

Interestingly, the study highlighted distinct network alterations in MDD patients compared to healthy controls. Hyperconnectivity was observed in PLV and AEC metrics, while wPLI—a measure sensitive to genuine phase lead-lag relationships—was decreased. Moreover, control nodes identified in patients were more centrally localized around the Cz electrode in the alpha and beta frequency bands, suggesting disease-specific hotspots for effective intervention.

These findings emphasize the paradigm shift from uniform neuromodulation approaches toward precision medicine in psychiatry. By exploiting mathematical frameworks and optimization algorithms, the research charts a course for data-driven, interpretable, and simulation-validated stimulation planning that respects individual neurophysiological variability. This methodological advance may ultimately augment response rates and reduce side effects associated with brain stimulation therapies.

The implications extend beyond clinical practice into the broader realm of computational neuroscience. Employing network controllability paradigms within functional brain data exemplifies a powerful strategy to unravel complex disorders characterized by distributed dysregulations. Furthermore, this study affirms the feasibility of combining multimodal metrics and advanced graph theory to pinpoint controllable states amenable to therapeutic modulation.

Despite these promising outcomes, translational challenges remain. Confirming the in-silico efficacy observed requires rigorous clinical trials incorporating real-time EEG-guided interventions. Additionally, practical considerations around stimulation device precision, patient compliance, and longitudinal monitoring must be addressed. Nonetheless, this work lays a sophisticated foundation for such endeavors.

As mental health disorders continue to exact a heavy societal toll, innovations leveraging artificial intelligence, brain network analytics, and evolutionary algorithms offer a beacon of progress. The union of computational rigor with clinical insight has the potential to transform how depression and other neuropsychiatric diseases are managed, shifting the narrative from symptomatic treatment toward mechanistically informed cures.

In summary, this novel EEG-guided framework represents a landmark achievement by providing individualized, optimized brain stimulation targets designed to mitigate the network disturbances underpinning major depressive disorder. Its fusion of cutting-edge computational methods with neurophysiological data heralds a new era in precision neuromodulation and underscores the transformative capacity of interdisciplinary research in mental health.

Subject of Research: Personalized brain stimulation targeting for major depressive disorder using EEG-based network analysis and multi-objective optimization.

Article Title: Personalized EEG-guided brain stimulation targeting in major depression via network controllability and multi-objective optimization

Article References:
Wang, A., Sun, J. Personalized EEG-guided brain stimulation targeting in major depression via network controllability and multi-objective optimization. BMC Psychiatry 25, 723 (2025). https://doi.org/10.1186/s12888-025-07171-x

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12888-025-07171-x

The salience network is instrumental in modulating how the brain prioritizes external stimuli and internal thoughts, dynamically balancing activity between the default mode network and executive control systems. Comprising brain regions such as the fronto-insular cortex, dorsal anterior cingulate cortex, amygdala, and temporal poles, this network plays a pivotal role in reward processing, emotional regulation, and cognitive flexibility. The recent research illuminated that in patients with depression, this network’s functional connectivity is increased to such an extent that its effective size is approximately twice that of non-depressed individuals, an alteration that remains consistent regardless of treatment or symptom progression.

Dr. Nicholas Fabiano, a lead co-author from the University of Ottawa’s Department of Psychiatry, emphasized the significance of these findings, explaining that the enlarged salience network exists prior to the clinical manifestation of depression and remains stable across different stages of the disorder. This suggests that rather than a transient response to mood disturbances, this neural feature represents a predispositional biomarker. As such, it has the potential to identify individuals at elevated risk for depression long before symptoms emerge, opening the door to preemptive interventions that could dramatically alter disease trajectories.

Depression is recognized globally as a leading cause of disability, with millions affected each year and many cases slipping underdiagnosed until symptoms become debilitating. Despite advances in psychosocial approaches and pharmacotherapy, the reliability of diagnosis remains limited, largely dependent on subjective assessments. The identification of a quantifiable biomarker — particularly one rooted in brain connectivity — offers an objective method that could augment clinical evaluation, facilitate earlier detection, and personalize treatment strategies.

The mechanisms that underlie this expansion of the salience network remain an active area of investigation. Researchers postulate several plausible hypotheses. One posits that the enlargement reflects a compensatory neural adaptation: predisposed individuals may increasingly recruit this network in efforts to manage emerging mood regulation challenges, resulting in its apparent hypertrophy. Alternatively, genetic factors might inherently shape brain architecture, conferring a vulnerability signature that precedes clinical onset. A third possibility is that relative network expansion arises secondary to atrophy in other cortical regions implicated in depression, such as the insular and anterior cingulate cortices, shifting the brain’s functional topology.

Co-author Dr. Robin Carhart-Harris from the University of California San Francisco’s Weill Institute for Neurosciences provides critical context on these hypotheses, noting that while the overlap in brain areas affected by atrophy and salience network expansion is notable, discrepancies point toward complex network interactions rather than unilateral structural changes. This underscores the multifaceted nature of depression as a neurobiological disorder, characterized by intricate alterations across brain-wide connectivity patterns rather than isolated neuronal deficits.

Traditional perspectives on depression have predominantly focused on neurotransmitter imbalances, with treatments engineered around chemical modulation. However, these new insights necessitate a reconsideration of depression as a condition fundamentally rooted in altered neural network connectivity. Such a conceptual shift has profound implications for therapeutics, suggesting that successful interventions must restore or normalize dysfunctional network interactions rather than merely correcting chemical signaling abnormalities.

Emergent therapies, including next-generation antidepressants, neuromodulatory techniques such as electroconvulsive therapy and transcranial magnetic stimulation, lifestyle interventions like exercise and diet modification, as well as experimental approaches involving ketamine and psychedelic-assisted therapy, may exert their beneficial effects, in part, by reshaping the salience network’s functional dynamics. Understanding how these diverse treatments modulate this network could open avenues to optimize efficacy and develop novel connectivity-targeted interventions.

A particularly promising frontier lies in longitudinal studies designed to track the salience network’s evolution in individuals undergoing treatment. Such research would elucidate whether therapeutic approaches can reverse or attenuate network expansion, and correlate these changes with clinical outcomes. Demonstrating the plasticity of the salience network and its responsiveness to interventions could cement its role as both a biomarker and a treatment target, dramatically improving prognostic accuracy and personalizing care.

Moreover, this discovery raises critical questions about the specificity of salience network alterations to depression. Given the symptom overlap across psychiatric disorders such as anxiety, bipolar disorder, and schizophrenia, future work must investigate whether an enlarged salience network is unique to depressive pathology or represents a transdiagnostic marker of emotional dysregulation. Clarifying this distinction will refine diagnostic categorization and therapeutic decision-making.

The collective findings of this commentary underscore the urgency to adopt a holistic, network-centric model of depression in both research and clinical contexts. By transcending reductionist paradigms fixated on isolated brain regions or neurotransmitters, the field moves closer to unraveling the complex neurobiological underpinnings of mood disorders. Such advances carry the promise of transforming mental health care—from reactive symptom management to proactive, mechanism-driven prevention and treatment.

This seminal work emerges at a critical juncture where mental health burden continues to escalate globally, exacerbated by sociocultural challenges and under-resourced systems. Objective biomarkers like the expanded salience network offer hope to enhance diagnostic precision, guide effective intervention strategies, and ultimately improve the quality of life for millions struggling with depression.

The full peer-reviewed commentary, entitled “The salience network is functionally twice as large in depression: The first depression biomarker?”, is freely accessible under Open Access in the May 13, 2025 edition of Genomic Psychiatry. This publication marks an important milestone in the quest to integrate genetic, neural, and clinical data toward comprehensive models of psychiatric illness.

As we deepen our understanding of neural networks and their roles in mental health, the expanded salience network may not only represent a biomarker but also illuminate new pathways for therapeutic innovation. Continued multidisciplinary efforts bridging psychiatry, neuroscience, genetics, and computational modeling will be essential in harnessing this discovery to transform depression diagnosis and treatment in the coming decades.

Subject of Research: People

Article Title: The salience network is functionally twice as large in depression: The first depression biomarker?

News Publication Date: 13 May 2025

Web References: http://dx.doi.org/10.61373/gp025c.0041

References: Lynch et al., Nature (detailed reference not provided in original content)

Image Credits: Nicholas Fabiano

Keywords: Depression, Salience Network, Biomarker, Brain Connectivity, Neural Networks, Psychiatric Diagnosis, Neuroimaging, Mental Health, Functional MRI, Neuroplasticity, Early Intervention